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Background: The prevention of near and actual cardiopulmonary arrest in hospitalized children is a patient safety
imperative. Prevention is contingent upon the timely identification, referral and treatment of children who are
deteriorating clinically. We designed and validated a documentation-based system of care to permit identification
and referral as well as facilitate provision of timely treatment. We called it the Bedside Paediatric Early Warning
System (BedsidePEWS). Here we describe the rationale for the design, intervention and outcomes of the study
entitled Evaluating Processes and Outcomes of Children in Hospital (EPOCH).
Methods/Design: EPOCH is a cluster-randomized trial of the BedsidePEWS. The unit of randomization is the
participating hospital. Eligible hospitals have a Pediatric Intensive Care Unit (PICU), are anticipated to have
organizational stability throughout the study, are not using a severity of illness score in hospital wards and are
willing to be randomized. Patients are >37 weeks gestational age and <18 years and are hospitalized in inpatient
ward areas during all or part of their hospital admission.
Randomization is to either BedsidePEWS or control (no severity of illness score) in a 1:1 ratio within two strata
(<200, ≥200 hospital beds). All-cause hospital mortality is the selected primary outcome. It is objective, independent
of do-not-resuscitate status and can be reliably measured. The secondary outcomes include (1) clinical outcomes:
clinical deterioration, severity of illness at and during ICU admission, and potentially preventable cardiac arrest; (2)
processes of care outcomes: immediate calls for assistance, hospital and ICU readmission, and perceptions of
healthcare professionals; and (3) resource utilization: ICU days and use of ICU therapies.
Discussion: Following funding by the Canadian Institutes of Health Research and local ethical approvals, site
enrollment started in 2010 and was closed in February 2014. Patient enrollment is anticipated to be complete in
July 2015. The results of EPOCH will strengthen the scientific basis for local, regional, provincial and national
decision-making and for the recommendations of national and international bodies. If negative, the costs of
hospital-wide implementation can be avoided. If positive, EPOCH will have provided a scientific justification for the
major system-level changes required for implementation.
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The Evaluation of Processes of care and the Outcomes
of Children in Hospital (EPOCH) study is a cluster-
randomized trial comparing the effect of the Bedside
Paediatric Early Warning System (BedsidePEWS) with
standard care. The outcomes are clinical, processes of
care and resource utilization. Here we describe the ra-
tionale for the trial, the intervention and the outcomes
used, conflict of interest management and the potential
impact of the study.
The problem and current treatments
Cardiopulmonary arrest occurs in 0.1-20/1000 children
in hospital wards [1-4], with hospital survival of 27-50%
[5-7]. Despite optimal resuscitation and post-arrest care,
in-hospital cardiac arrest is associated with significant
mortality and acquired morbidity in survivors [3,6,8-11],
making prevention the best strategy [6,8,12-23].
Prevention of near and actual cardiopulmonary arrest
Prevention of near and actual cardiopulmonary arrest in
hospitalized children is a patient safety imperative. Pre-
vention is contingent upon the timely identification, re-
ferral and treatment of children whose conditions are
clinically deteriorating [24,25]. Preventative strategies
have focused on the latter portion of this sequence, pri-
marily through improved access to ICU expertise
through deployment of Medical Emergency Teams-
Rapid Response Teams (MET-RRT). However, studies
addressing methods to identify those in need have been
few and of limited quality [26].
Emergency response teams
To date, MET-RRT have not fulfilled their promise. In
adult inpatients, following several positive [27-29] and
negative [30-33] single-center studies, a 23-hospital,
cluster-randomized clinical trial compared implementa-
tion of un-validated calling criteria plus MET-RRT with
standard care (no MET-RRT, no explicit calling criteria).
The primary outcome was a composite of unexpected
death, unplanned ICU admission and cardiac arrest. This
negative trial [34] provides several important lessons: (1)
calling criteria were met in <50% of patients with urgent
ICU admission, suggesting that the criteria did not iden-
tify patients at risk. (2) The number of patients without
unexpected death, unplanned ICU admission or cardiac
arrest, who met one or more of these calling criteria is
unknown (similar to pediatric studies) [35-39]. (3) Ap-
proximately 90% of the patients who met criteria were
referred to ICU teams in both MET and control hospi-
tals, suggesting that the calling criteria added little to the
standard model.
In children, only before-and-after studies have been
published [35-39], of which one is multi-center [40]. Thetwo studies showing reduced all-cause hospital mortality
were performed over 6 [36] and 7½ years [38], influ-
enced the findings of a systematic review of pediatric
MET-RRT [41], which include no RCTs, and reinforced
the potential for description of time-related improve-
ment [42,43] to be ascribed to MET-RRT. Furthermore,
the additional benefit from MET-RRT without appropriate
‘afferent limb’ identification mechanisms may be question-
able in hospitals where the efferent limb response-ICU ex-
pertise is readily available [25].
Mechanisms to identify children at risk for near and
actual cardiopulmonary arrest
There are eight published pediatric mechanisms to iden-
tify children at risk for cardiac arrest [1,35,37,44-47].
The development of most has been methodologically
limited [48]. There are four published calling criteria
[35,37,46,47]. The Cincinnati criteria include subjective
elements and have been modified [35,49]. The Baltimore
criteria are subjective and/or triggered by acute medical
diagnoses [37]. The Bristol tool is subjective and uses
thresholds for the airway (nebulized epinephrine, ‘tiring’)
and disability [46]. The Melbourne criteria identified 10/
24 (42%) patients who had cardiac arrests in their hos-
pital [38] and similar proportions in other hospitals
[40,50].
There are four published pediatric scores [1,44,45,48].
The Brighton score uses behavior, circulatory (color,
relative tachycardia) and respiratory (relative tachypnea)
domains and ‘persistent vomiting following surgery’ with
a range of 0 –11 [44]. Evaluation of this score in a co-
hort of 2979 children in Cincinnati Children’s Hospital
found a sensitivity of 78% and specificity of 82% [49]. In
the development cohort, the Cardiff and Vale score had
a sensitivity of 69% and specificity of 90%. Inspection of
the score reveals that children in the first months of life
may be expected to routinely score at or above the
threshold (2 points for systolic blood pressure <70
mmHg and respiratory rate >50 breaths/min) [45].
The BedsidePEWS
The BedsidePEWS score differentiated between children
who were urgently admitted to PICU and ‘well’ hospital-
ized children, with at least 1 h notice with a sensitivity
of 83% and specificity of 95% [48]. In a multi-center val-
idation study of 2074 patients the score performed well
in sub-populations [51]. Among ‘case patients’ the score
increased over time leading up to an urgent PICU ad-
mission or code-blue event, and was independent of the
number of risk factors for cardiac arrest. [51].
The score was reliably calculated with an intraclass
correlation coefficient of 0.92 and was associated with
statistically significant improvements in clinical and process
of care outcomes [52]. The quality of development,
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sion that the BedsidePEWS score is equivalent or superior
to others and provides a rationale for its use as the inter-
vention in EPOCH (Table 1).
The objectives of EPOCH are to evaluate the impact
of the BedsidePEWS on early identification of children
at risk for near and actual cardiopulmonary arrest, hos-
pital mortality, processes of care and ICU resource
utilization. We hypothesize that the BedsidePEWS im-
proves early detection of critical illness, reduces mortal-
ity, improves processes of care and does not increase
healthcare resource utilization.
Methods
EPOCH is a cluster-randomized trial comparing the
BedsidePEWS with standard care (no severity of illness
score) in hospitals with a pediatric intensive care unit
(ICU). The unit of randomization is the participating
hospital. Eligible hospitals provide care for more than a
total of 200 eligible inpatient admissions in eligible in-
patient wards each year, have specialized pediatric physi-
cians and have at least one PICU. Eligible inpatient
wards are defined as areas where care is provided to
children who are admitted to the hospital, other than
the NICU, PICU, operating rooms and other designated
areas where anesthetist-supervised procedures are per-
formed. Emergency departments that care for admitted
patients may be regarded as an eligible ‘ward’ (Table 2).
Eligible patients are >37 weeks gestational age and <18
years, and they have received care in an eligible inpatient
ward. To ensure that major system changes do not
introduce bias, we will exclude hospitals that plan to
introduce or discontinue an MET-RRT during the study,
are already using a severity of illness score in wards or
consider randomization unacceptable. Hospitals with a
pre-existing MET-RRT are eligible to participate.
Intervention: BedsidePEWS
The BedsidePEWS documentation-based system of care
replaces existing documentation systems for vital signs
in inpatient ward areas in hospitals randomized to the
intervention. There are four elements in the system: (1)
the BedsidePEWS score; (2) the BedsidePEWS docu-
mentation record; (3) score-matched care recommenda-
tions, developed using the responses of 280 healthcare
professionals (80 community, 200 referral) surveyed toTable 1 Differences between BedsidePEWS and other severity
(1) A validated severity of illness score that is better at ide
(2) Complete integration of scoring into routine documen
(3) Explicit care recommendations derived from the opini
(4) Nurse-educator developed, provider tested implement
(5) Pilot evaluation showing improved outcomes withoutdetermine ‘reasonable’ care in each of the domains of
vital sign assessment, secondary review, continuous
monitoring and ICU consultation, and customized for
each implementation; (4) the education program, devel-
oped by two nurse educators to support implementation
and maintain expertise, including the BedsidePEWS In-
structor course and frontline education program.
Randomization
Participating hospitals are randomized in a 1:1 ratio to
intervention or control. Computerized randomization is
balanced by the use of two strata of hospital size: <200
vs. ≥200 eligible inpatient ward beds. Allocation is con-
cealed until the start of the study measurements and is
revealed in the 2nd week after the start of data collection
at each site (Additional file 1).
Primary outcome: all-cause hospital mortality
The primary outcome is all-cause hospital mortality in
eligible inpatients who were cared for in an eligible in-
patient ward at some point during their hospital stay.
This includes anticipated deaths in children with ‘do not
resuscitate’ orders. Mortality events in children cared for
exclusively in the PICU, NICU or emergency depart-
ment, or combinations thereof, are excluded.
Secondary outcomes: clinical
The main secondary outcome is the significant clinical
deterioration event (SCDE), a composite outcome com-
prised of the treatment(s) provided or death prior to
transfer from an inpatient ward. An SCDE is defined as
the provision of significant pre-specified respiratory or
circulatory therapies or cardiopulmonary resuscitation in
the 12 h before transfer from the inpatient ward or dur-
ing the hour after transfer, or death without a DNR
order in an inpatient ward (Table 2).
EPOCH includes eight additional clinical outcomes
(Table 3): (1) the nature of SCDE rated on the seven-
point Children’s Resuscitation Intensity Scale (Table 4),
which measures the timing of interventions in children
for whom active resuscitation is anticipated; (2) poten-
tially preventable cardiac arrest in patients experiencing
a cardiac arrest while in an eligible inpatient ward. This
excludes patients with a preceding DNR order. Poten-
tially preventable is defined as the degree to which
‘events may have been avoided given the application ofof illness scores
ntifying patients at risk than the retrospective opinion of frontline nurses
tation
ons of 280 healthcare professionals
ation program
additional resources
Table 2 Study definitions
Eligible inpatient
wards
Areas where care is provided to patients who are admitted to the hospital, other than the PICU, NICU, operating rooms and
other designated areas where anesthetist-supervised procedures are performed
Admitted patients cared for in emergency departments will be regarded as in an eligible ‘ward’ if the documentation format is
the same in the emergency department as in the inpatient ward. If the emergency department continues to use a separate
‘emergency department’ documentation record for admitted patients then the emergency department will be deemed an
ineligible area
PICU A PICU is defined as a designated staffed area for prolonged mechanical ventilation, invasive monitoring and circulatory
support for children, including but not limited to neonates. Other areas designated for patients of increased acuity, such as
‘constant observation’ or ‘high dependency’ or ‘step-down’ units, will be regarded as part of the PICU where the PICU staff
physicians are wholly or jointly responsible for the care of children in these areas (can write orders in the chart). Routinely
admitted patients will include children beyond the neonatal period who are <12 years of age at admission
MET-RRT An MET-RRT is defined as an identified team of one or more trained healthcare professionals who report to an on-service PICU
physician and perform urgent consultations on hospital inpatients. An MET-RRT ‘call’ is analogous to an ICU consultation in hos-
pitals without an MET-RRT. As the effectors of expertise, the impact of the MET-RRT (or other ICU team) is dependent upon ap-
propriate identification of patients at risk and timely referral
Urgent PICU
admission
An admission to the PICU with departure from the event location in <6 h from the time the PICU admission was initiated.
Initiation is the time when the PICU admission is confirmed, or confirmed as a ‘definite possibility following surgery’ in cases
where post-operative care in the PICU might be required. PICU admissions initiated in the OR are also regarded as urgent ICU
admissions, irrespective of the time between initiation and departure from the OR
Time of transfer Transfer is when a patient is transferred urgently to a pediatric intensive care unit (PICU) in the participating hospital. The time
of transfer is the arrival in the PICU. When a patient is admitted urgently from an eligible hospital ward to a PICU via a
procedure in the OR, the time of transfer to the ‘PICU’ is regarded as beginning at the time of departure from the inpatient
ward to the operating room. Treatments other than cardiopulmonary resuscitation provided in the operating room are not
included in the calculation of the clinical deterioration event. Unexpected events occurring in the operating room that require
postoperative/post-anesthetic care in the PICU, in patients who were not anticipated to require PICU at the time the patient
was transferred from the inpatient ward to the operating room, will not be regarded as clinical deterioration events
Study Day Study days are calendar days; they begin at 00:00:00 and end at 23:59:59
Study weeks begin on Monday and end on Sunday. The first week of the study is study week 01
Parshuram et al. Trials  (2015) 16:245 Page 4 of 12reasonable current (2011-13) standards of practice by an
average practitioner and system anticipated to manage
the condition in question’ [53-57]. Events with a consen-
sus rating from two expert reviewers of ≥4/6 are defined
as potentially preventable cardiac arrests (Table 5)
[55,56]. (3) Unplanned hospital re-admission; (4) urgent
PICU re-admission, both within 48 h of discharge. Fi-
nally, in all patients admitted urgently to the PICU from
a hospital inpatient ward measurement was made of: (5)
the predicted risk of mortality (PIM2 score) [58,59], (6)
PICU mortality, (7) organ dysfunction (PELOD score)
[60] and (8) ventilator-free days to 28 days. Urgent PICU
admission is defined as departure from the inpatient
ward within 6 h of the decision to admit to the ICU
(Table 2). This definition reflects the need to pragmatic-
ally distinguish between urgent and elective admission
and the recognition that most urgent admission occurs
within 1-2 h of the decision to transfer to an ICU.
Secondary outcomes: process of care
The study includes five processes of care assessments:
(1) ‘Stat’ calls. This was formally defined (Table 3), and a
consistent approach to data collection was applied
throughout the study, recognizing that cultural and
other factors may contribute to considerable inter-
hospital variability. (2) Code Blue calls for immediate
medical assistance of the resuscitation team andequipment. (3) Urgent consultations (within 15 min) to
the ICU or MET-RRT. (4) Using documentation from
five randomly (central computerized randomization) se-
lected patients each week, physician visits, the nurse:pa-
tient ratio and the use of continuous monitoring are
described. (5) Frontline staff complete the documenta-
tion and interaction survey (2 pages, <10 min to
complete) that describes their perceptions of the docu-
mentation system and the nature of interactions with
physicians (Additional file 2: CRF). This custom-built
survey was developed and used in our pilot evaluations
of BedsidePEWS. It has not been formally validated.Secondary outcomes: resource utilization and decision-
maker perceptions
Resource utilization is assessed in all hospitals by meas-
urement of hospital length of stay and for patients
undergoing urgent ICU admission, ICU length of stay
and the days of use of the ICU technologies: mechanical
ventilation, hemodialysis, ECMO and nitric oxide. A
purpose-built survey of the perceptions of hospital
decision-makers will be conducted 3 months after the
end of the 12-month intervention period (Table 3) to de-
scribe the experience of the decision-maker in partici-
pating in a hospital-wide cluster RCT and their
expectations of its results.
Table 3 EPOCH secondary outcomes
Clinical
(1) Significant clinical deterioration event See Table 4
(2) The nature of clinical deterioration events Clinical deterioration events will be described by using the Children’s Resuscitation Intensity Scale
(Table 4). Urgent PICU admissions that are initiated when the patient is in the operating room
will not be regarded as clinical deterioration events
(3) Potentially preventable cardiac arrest Assessment of the potential preventability of cardiac arrest will be determined for all patients
who had a cardiac arrest event while in an eligible inpatient ward, without a preceding DNR
order (Table 5)
Thus, potential preventability ratings of 4: ‘more than likely (more than 50/50, but “close call”);’ 5:
‘strong evidence of preventability;’ 6: ‘virtually certain evidence of preventability’ will be deemed
potentially preventable cardiac arrest events
Preventability will be rated by blinded reviewers reviewing anonymized and delinked clinical data
presented in a standardized format. If consensus between the two initial reviewers still cannot be
reached then the opinion of the third reviewer will be used as the consensus rating
(4) Unplanned re-admission to the hospital within
48 h of hospital discharge
This outcome will be operationalized as re-admission before midnight of the second day full day
after discharge. Thus, re-admission will occur before the 3rd midnight following hospital
discharge
(5) Unplanned PICU readmission within 2 days of
PICU discharge
This outcome will be operationalized as re-admission before midnight of the second full day after
discharge. Thus, re-admission will occur before the 3rd midnight following PICU discharge
(6) PIM score predicted the risk of mortality
(7) PICU mortality.
(8) The PELOD score for PICU stay and the first 24
h in PICU
This score will be determined for both the entire PICU stay and the first 24 h in the PICU
(9) Ventilator-free days Days alive and without invasive mechanical ventilation in the 28 days beginning at PICU
admission will be recorded for the first PICU admission during each of the baseline and the post-
randomization periods
Process of care
(1) ‘Stat’ calls to physicians Requests for immediate specific physician attendance to provide patient care to a patient
admitted to an inpatient ward
(2) Code Blue calls Immediate medical assistance of the resuscitation team and equipment
(3) Urgent consultations to the ICU or MET-RRT The total number of new consultation episodes will be counted. Patients who have been
previously consulted on will be regarded as having a new consult if an urgent call is made that
results in an unplanned or earlier than planned review. Planned review involves visits by the ICU
team or the MET-RRT
(4) Documentation The frequency with which each of the ‘vital’ signs (HR, RR, SBP, temperature) and the other four
signs of the Bedside PEWS score (transcutaneous oxygen saturation, respiratory effort, oxygen
therapy, capillary refill) is documented in 24 h will be recorded from five randomly selected
patients each week
Resource utilization
Hospital length of stay Will be assessed as the number of patient discharges divided by the number of patient days
following urgent ICU admission
ICU length of stay This will be expressed as the number of whole or part study days (00:00:00 – 23:59:59) a given
patient was in the ICU
Ventilator days This is the number of whole or part study days of invasive mechanical ventilation
Dialysis ‘Dialysis’ will include hemo-filtration and hemodialysis techniques used either intermittently and
continuously (or both), peritoneal dialysis, plasmaphersis and red-cell exchange
ECMO (days) This is the number of whole or part study days of extracorporeal membrane oxygenation therapy
provided during the ICU stay
Days with nitric oxide This is the number of whole or part study days of inhaled nitric oxide therapy provided during
the ICU stay
Perceptions of healthcare professionals
Documentation and interaction survey A 10-min survey of frontline healthcare professionals to describe their perceptions of the utility of
the current documentation system, the nature of inter-professional interactions and their
background
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Table 3 EPOCH secondary outcomes (Continued)
Decision Maker Study exit survey Eligible decision-makers will include: hospital chief executive officers (CEOs), chief nursing officers
(CNOs), vice presidents and heads of a clinical department, divisions or services. Eligible services
include senior nursing administrators for inpatient ward areas, resuscitation committee heads and
medical emergency team leaders. At each hospital a maximum of ten eligible leaders will be
selected by the EPOCH study team
A minimum of four decision-makers will be identified: the CEO, CNO, clinical head of pediatric
surgery and clinical head of pediatric medicine. Hospitals with more than 80 beds will identify 2
additional decision-makers; hospitals with more than 120 beds will identify 4 additional decision-
makers, and hospitals with more than 180 beds will identify an additional 6 decision-makers
Parshuram et al. Trials  (2015) 16:245 Page 6 of 12All outcomes are assessed prospectively. The first 26
weeks are baseline data. Then following a 5-week run-in
period in intervention hospitals or break from data col-
lection in control hospitals, outcomes are assessed pro-
spectively for 52 weeks (Additional file 1).
Sample size and assumptions
Power calculations are based on population estimates
derived from 14 local hospitals’ data using a published
method for cluster RCTs [61]. For all-cause mortality we
found a baseline rate of 5.1/1000. The steering commit-
tee agreed that a mortality reduction of less than 1/1000
admissions would not be a compelling reason to modify
practice. A study with 20 hospitals can show an 18%
relative risk reduction in mortality (absolute risk reduc-
tion 0.09%), given alpha = 0.05 (2-sided), power = 80%,
mean of 119 pediatric beds, length of stay = 4 days, with
0.90 average occupancy, k = 0.15, n = 20, baseline rate =
5.1/1000. The quantity k is the coefficient of variation
for mortality between hospitals. Assuming attrition of 1-
2 hospitals, we will include a sample of 22 hospitals.
Data from 4 pediatric hospitals in Ontario indicate
there are 1052 urgent ICU admissions/year, of which
we estimate 40% involve SCDE, for a rate of 2 perTable 4 Clinical deterioration events
Definition
1 Early transfer <60 ml/kg intravenous or intraosseous fluid resu
intraosseous inotrope or vasoactive medications
in the 12 h before transfer
2 Noninvasive respiratory
support
Positive pressure ventilation in the 12 h before
includes children receiving mask-delivered posit
at the time of transfer. Mechanical ventilation d
3 Invasive respiratory
support
Intubated and/or receiving endotracheal ventila
admission
4 Circulatory >60 ml/kg intravenous or intraosseous fluid resu
any intravenous or intraosseous inotrope or vas
preceding transfer. Patients in this category may
5 Late transfer Respiratory (3) and circulatory (4) support before
6 Cardiopulmonary
resuscitation
Chest compressions before transfer from ward a
or within 1 h of PICU admission
7 Death Death on an inpatient ward, other than in those
intention to perform CPR if patient is pronounc
ECMO extracorporeal membrane oxygenation therapy.
*SCDE significant clinical deterioration event.thousand patient days. Thus, with 20 sites we will be
able to show a 31% reduction in SCDE [alpha = 0.05 (2-
sided), power = 80%, k = 0.15, where k is the coefficient
of variation for SCDE rate between hospitals]. The
value of k allows for a moderate amount of clustering
within hospital.Data analysis
Demographic and unadjusted outcomes data will be re-
ported using means, median, variances, interquartile
ranges or as proportions with 95% confidence intervals.
Outcomes will be reported for the baseline and interven-
tion periods for each hospital consistent with published
recommendations for cluster randomized trials [62].Primary analysis
All-cause hospital mortality will be evaluated using a
logit regression model. The dependent variable will be
the logit of the proportion dying in each hospital. The
independent variables will include a dummy indicator
for treatment arm, the baseline mortality logit and the
hospital size stratification variable. The analysis will be
weighted by the size of the hospital.SCDE*
scitation given in the 12 h before transfer, no intravenous or
and no positive pressure ventilation (bag mask or endotracheal)
No
transfer, but not intubated at the time of transfer. This category
ive airway pressure at any stage in the 12 h before transfer and
uring anesthesia for a scheduled procedure is not included
No
tion at the time of transfer or intubated within 1 h of PICU Yes
scitation given in the 12 h before transfer, and administration of
opressor at the time of transfer or at any stage in the 12 h
also receive positive pressure ventilation (2)
Yes
transfer Yes
rea or within 1 h of PICU admission or ECMO instituted before Yes
patients with DNR orders. Death may occur despite CPR (or
ed dead without CPR). No transfer from ward area
Yes
Table 5 Potential preventability criteria
Rating Category
1 Virtually no evidence of preventability
2 Slight-to-modest evidence of preventability
3 Preventability not quite likely (less than 50/50, but “close call”)
4 Preventability more than likely (more than 50/50, but “close call”)
5 Strong evidence of preventability
6 Virtually certain evidence of preventability
Criteria used to determine potential preventability in EPOCH. These criteria were used in the Canadian Adverse Events Study. A rating of 4 or more will be
regarded as a high degree of preventability. Potentially preventable cardiac arrests will be presented as rate per thousand patient-days.
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An identical logit model will be used for ICU mortality
after urgent ICU admission where the PICU admission
was initiated in a hospital ward, ICU mortality after ur-
gent ICU admission initiated in the OR, unplanned hos-
pital re-admission within 2 days of hospital discharge
and mortality following DNR orders.
Significant clinical deterioration events, Code Blue
events, stat calls and urgent PICU consultations per
1000 patient-days will be evaluated using Poisson regres-
sion using hospital-level aggregated count data. The in-
dependent variables will include a dummy indicator for
treatment arm, the baseline event rate and hospital size
stratification variable. A linear regression model, in
which the within-hospital mean is the dependent vari-
able, will be used to evaluate the nature of SCDE, in-
patient ward patient-days, and for patients admitted
urgently to the PICU, PIM2 score, PELOD score,
ventilator-free days, ICU patient-days and ICU therapy-
days. The independent variables will include a dummy
indicator for treatment arm, the baseline means and
hospital size stratification variable. The analysis will be
weighted by the size of the hospital.
An identical linear regression model will be used to
evaluate the frequency of vital sign documentation from
the randomly selected patient records. Since the number
of records abstracted will be the same in each hospital,
weighting will not be necessary. Documentation will be
evaluated as follows: the number of heart rate, respira-
tory rate, systolic blood pressure, trans-cutaneous oxy-
gen saturation, capillary refill, oxygen therapy and
respiratory effort measurements, and the number of
times that all seven items were documented will be com-
pared for patients in hospitals with and without Bedside-
PEWS. All analyses will adjust for baseline event rates
and hospital strata. Linear regression will be used to
compare the numbers of (1) vital signs documented, (2)
documented physician visits, (3) the nurse: patient ratio,
the use of (4) continuous ECG monitoring and (5) con-
tinuous pulse oximeter monitoring with the Bedside-
PEWS scores calculated from the abstracted clinical
data.Analysis of the documentation and interaction survey
and the post-study decision-maker survey data will com-
pare groups using linear regression weighted by the size
of the hospital.
The following four pre-specified subgroup analyses
will be performed. (1) Hospital size. Hospitals will be
classified on the basis of the number of eligible inpatient
ward beds. Hospitals with ≥200 eligible inpatient ward
beds will constitute one group and those with <200 eli-
gible inpatient ward beds the other. This is consistent
with the stratification method used for randomization.
(2) Hospitals with and without MET-RRT. (3) Hospitals
with ECMO for children. (4) Patients with urgent PICU
admission initiated in an inpatient ward.
Planned conduct
Initial application for funding was made in September
2009, accompanied by 18 letters from hospital CEOs or
other senior administrators indicating willingness for
their hospital to participate. Successful re-submission in
March of 2010 preceded announcement of funding in
July 2010. Study resources were obtained from Canadian
Institutes of Health Research (CIHR). After approval of
$4 million by the reviewing panel, a budget of $3.3 mil-
lion was granted. Funds were released by the CIHR in
December 2010 following recruitment and approval of
the three-person data safety and monitoring board, clin-
ical trial registration (CTN#1000018562) and Research
Ethics Board (REB-IRB) approval at the sponsoring insti-
tution. The study coordinating center is at the Center
for Safety Research at the Hospital for Sick Children,
Toronto. The study staff is supported by the infrastruc-
ture of the Child Health Evaluative Sciences Program of
the Research Institute of the Hospital for Sick Children.
EPOCH REB-IRB applications sought and obtained
waiver of patient-level consent (Table 6). The local docu-
mentation system is used as a part of routine hospital
practice, patient-level data are retrospectively obtained
and precedent exists in Canada and the UK [51,52]. Fur-
thermore, consent for the participation of 100,000 pat-
ents is not feasible, and if required, would significantly
undermine the scientific validity of the study. REB-IRB
Table 6 Rationale for waived patient consent in EPOCH
1 Consent for routine documentation practice is implied with hospital admission + this is also true for other practices including staffing, ICU
consultation, physician review
+ Documentation is an inherent and routine part of hospital care
+ In intervention hospitals the BedsidePEWS becomes the accepted standard for documentation
+ In control hospitals and before implementation in hospitals randomized to implement BedsidePEWS, consenting to routine care in a situation
where that there is no alternative is counter-intuitive
2 Patient-level data are retrospectively obtained and + does not require patient contact
+ does not require additional clinical investigation
+ precedent exists for waived consent for this type of data collection
3 Preemptive consent for events (including in-hospital cardiac arrest, death) that have not occurred - and that may not occur
+ Is potentially distressing to families
+ Is inefficient use of research resources
4 Obtaining consent is not feasible for 100,000 patients anticipated in the study sample
+ retrospective consent from families of deceased children may add burden and is potentially distressing to families
5 Incomplete enrollment would undermine and bias the scientific validity of the study
6 Data will be presented in aggregate.
No identifying information will leave the study office in the participating hospital
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healthcare professionals for staff surveys and the post-
study survey of administrative perspectives [52]. Hospital
recruitment though the networks of the CCCTG pre-
ceded the enrollment of hospitals with an identified site
investigator, administrative and research ethics board ap-
proval, and it was contingent on the number of sites pre-
viously enrolled in the study. The enrolled sites and
associated ethical approvals are provided in Additional
file 2.Conflict of interest management
There are two parties with conflict of interest that are
involved in EPOCH. These are the PI (CSP) and the host
institution, The Hospital for Sick Children, who are both
shareholders in a computerized decision support com-
pany (Bedside Clinical Systems). BedsidePEWS is an
FDA-approved product of Bedside Clinical Systems. The
study PI (CSP) is a named inventor of the BedsidePEWS
(US patent 12/669,896). The patent is owned by the host
institution (SickKids).
Study processes to ensure transparency, independence
and oversight are in place to manage these conflicts of
interest. First, EPOCH employs routine quality assurance
processes including Data Safety Monitoring Board Re-
view, annual reporting to CIHR, and scientific and oper-
ational oversight from the Executive Steering Committee
and the Canadian Critical Care Trials Group (CCCTG).
Second, the PI is separated from key study processes
including randomization, allocation concealment, data
inspection and the conduct of analyses. The study statis-
tician (AW) is responsible for overseeing the randomallocation of sites to intervention or control arms, super-
vises the project manager and uses a password-protected
account on randomizedtrials.net. The password is
known only to the project manager and statistician, who
complete the randomization process and inform the PI
and site investigators of the outcome during the first 2
weeks of data collection at each site.
Third, review of site progress in sites randomized to
implementation of the BedsidePEWS is conducted by
the Executive Steering Committee in the 4th week of the
run-in phase. The decision to complete or prolong the
run-in phase is made by the majority vote of the Execu-
tive Steering Committee. The PI does not vote.
Fourth, data integrity is ensured by three methods. (1)
Separation of data collection from randomization status
will be achieved by training site coordinators before
randomization, using standardized materials. (2) Inspec-
tion of study data during site visits is conducted by the
Center for Safety Research staff. If present, the PI will
not review primary study data. (3) Following creation of
the ‘locked’ data set, each site investigator receives a data
report to review, reconcile with the data from their site
and provide written confirmation that the data are cor-
rect or require reconciliation. Once confirmed by all site
investigators the final data set will undergo planned
analyses.
Fifth, once completed the analyses will be reviewed by
an independent statistician based at another university.
Sixth, the interpretation of the data and their reporting
in iterative drafts of the main study manuscript will be a
shared activity of the executive steering committee and
writing committee and will be complimented by pre-
submission review by independent CCCTG reviewers.
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Preliminary data suggest that the BedsidePEWS score
can identify patients at risk for near and actual cardio-
pulmonary arrest, can be calculated both rapidly and re-
liably and that its clinical implementation is associated
with potential improvements in patient and process of
care outcomes. The resource implications of system-
wide implementation, the previous lessons from the
MERIT study, and the uncertain effect on important
clinical outcomes underscore the relevance of the
cluster-randomized design, the selection of the interven-
tion and the outcomes used in EPOCH. EPOCH will be
conducted in 22 hospitals, involve an estimated 100,000
patients admitted for about 400,000 patient-days and de-
scribe approximately 1900 urgent ICU admissions, 200
cardiac arrest events and 500 deaths. Mortality in
hospitalized children is an objective measure of quality
of care and is used extensively to benchmark the per-
formance of PICUs [58,63-66], surgical programs and
hospitals [67-69].
All-cause hospital mortality was selected as the primary
outcome in EPOCH for the following reasons. First, mor-
tality is objective and can be reliably assessed. Second, a
reduction in all-cause hospital mortality is the ultimate
goal of any intervention to improve the outcomes of care
of hospitalized children. Third, observational studies of
MET-RRT have reported reduced all-cause mortality
[36,38]. Fourth, several studies show that when children
who have been hospitalized die, most do so in hospital
[70-73]. In a 6-year study of in-ICU cardiac arrest, we
found only one (1.4%) additional death after index-
hospitalization discharge and within 12 months of the
index cardiac arrest. Fifth, the effect of pediatric palliative
care services on displacing place of death to home or hos-
pice is small [72,74-77]. One large US study found the
proportion of deaths in the hospital decreased by less than
6% (from 85.7 to 80.1%) over a 10-year period [75]. Thus,
measuring hospital mortality provides a reasonably accur-
ate measure of mortality in children who have been or are
currently hospitalized.
As well, all-cause mortality is an established quality
metric in Canadian and British adult hospitals and is
publicly reported as the standardized mortality ratio in
Ontario Hospitals [68,69,78-80]. Finally, while death
‘with DNR’ vs. ‘unexpected’ deaths (no DNR) has been
used to distinguish ‘preventable’ from ‘unpreventable’
deaths following acute events in adult patients [34,81],
in hospitalized children there are significant limitations
to this distinction: (1) DNR orders reflect current expec-
tations of outcome and not the ‘preventability’ of the
preceding clinical events; (2) the majority of deaths in
hospitalized children, especially in the ICU, occur some
days after a clinical deterioration event [3,7,10,18,21,82],
but within a relatively short time (hours) between DNRorder and death [83-85]. Before confirming that a death
in a patient with a DNR order was truly unpreventable,
the clinical context and timeline of clinical deterioration
prior to the DNR order must be known. It must also be
recognized that medically ‘futile’ resuscitation may be
performed on hospitalized children [86] for whom no
DNR order is in place.
EPOCH outcomes are assessed for 1 year after
hospital-wide implementation of intervention or con-
tinuation of standard care. This duration was chosen to
reduce the effects of seasonal variation, but also to re-
duce the burden of a multi-year intervention period on
each hospital, thus increasing feasibility, and to support
timely completion of the study to support the decision-
making needs of administrators. Continued eligibility
will be confirmed by intermittent reporting of the MET-
RRT and Early Warning Score use during the course of
the study.
Limitations of EPOCH
EPOCH has some limitations. First, by excluding the use
other severity of illness scores, EPOCH will not provide
data comparing alternate scores. This more refined
question will need to be evaluated separately, preceded
by appropriate studies to support selection of best com-
parators. Evaluation of the ‘best available’ system is im-
portant for proof of concept, needed before these more
refined questions are addressed. Second, EPOCH does
not assess quality of life, parental perceptions or neuro-
cognitive outcome. All are relevant measures of the
process and outcome of care [11]. In other prospective
work we have shown that urgent ICU admission is asso-
ciated with reduced health-related quality of life and ac-
quired neuro-cognitive deficits [11]; thus, it would be
reasonable to include these measures as outcomes in
EPOCH. Exclusion of these elements was due to logistic
constraints; acquisition of these data for all admissions
would not be feasible, and following these urgent ICU
admissions would be both resource intense and would
require prospective consent/assent and follow-up. Fi-
nally, mortality may be both too coarse a measure and
too infrequent an event to demonstrate clinically im-
portant differences.
EPOCH is a 22-hospital cluster-randomized trial
evaluating the impact of the BedsidePEWS as a mechan-
ism to improve the identification of children with evolving
critical illness, reduce near and actual cardiopulmonary ar-
rest, and reduce all-cause hospital mortality in hospital-
ized children. The results of this trial will provide a
scientific basis for local, regional, provincial and national
decision-making and for recommendations to national
and international bodies [87], such as the AHA and Euro-
pean Resuscitation Council [88] about cardiac arrest pre-
vention and institutional best practices.
Parshuram et al. Trials  (2015) 16:245 Page 10 of 12If negative, the costs of hospital-wide implementation
can be avoided, resources more appropriately allocated
and the collaborative multi-site data set from the study
used to develop and evaluate new hypotheses about car-
diac arrest prevention and processes of care. If positive,
then EPOCH will have provided a scientific justification
for the major system-level changes required for imple-
mentation and supported the creation of evidence-based
policy.Trial status
At time of manuscript submission (October 2014)
ethical approvals had been obtained at each participating
site, study enrolment was complete, data collection had
ended in 19 hospitals and was anticipated to be com-
pleted by July 2015 in remaining sites.Additional files
Additional file 1: EPOCH study flow diagram. EPOCH timelines and
study flow diagram. Three periods are described: a 26-week baseline
period, a 5-week run-in phase during which hospitals randomized to
implement BedsidePEWS can become familiar with the implementation
and a 52-week post-randomization phase. The blue stars represent the
administration of the Documentation and Interaction Survey, and the ‘Q’
represents administration of the decision-maker survey. Randomization
occurs in the second week of data collection, and allocation is revealed
to the primary investigator and relevant site investigator during the
second study week.
Additional file 2: We list the participating Hospital, the approving
Approving Research Committee and the associated reference
number for participating sites in the EPOCH cluster randomized
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